chr1-218379955-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003238.6(TGFB2):​c.347-25214A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.17 in 152,140 control chromosomes in the GnomAD database, including 2,226 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.17 ( 2226 hom., cov: 32)

Consequence

TGFB2
NM_003238.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0490

Publications

13 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD, Unknown Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003238.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.202 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003238.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
NM_003238.6
MANE Select
c.347-25214A>G
intron
N/ANP_003229.1P61812-1
TGFB2
NM_001135599.4
c.430+16538A>G
intron
N/ANP_001129071.1P61812-2
TGFB2
NR_138148.2
n.1713-25214A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
ENST00000366930.9
TSL:1 MANE Select
c.347-25214A>G
intron
N/AENSP00000355897.4P61812-1
TGFB2
ENST00000366929.4
TSL:1
c.430+16538A>G
intron
N/AENSP00000355896.4P61812-2
TGFB2
ENST00000488793.1
TSL:3
n.11-25214A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.170
AC:
25839
AN:
152022
Hom.:
2224
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.150
Gnomad AMI
AF:
0.182
Gnomad AMR
AF:
0.166
Gnomad ASJ
AF:
0.174
Gnomad EAS
AF:
0.177
Gnomad SAS
AF:
0.212
Gnomad FIN
AF:
0.186
Gnomad MID
AF:
0.171
Gnomad NFE
AF:
0.175
Gnomad OTH
AF:
0.199
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.170
AC:
25875
AN:
152140
Hom.:
2226
Cov.:
32
AF XY:
0.172
AC XY:
12788
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.151
AC:
6246
AN:
41494
American (AMR)
AF:
0.167
AC:
2553
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.174
AC:
605
AN:
3472
East Asian (EAS)
AF:
0.178
AC:
920
AN:
5176
South Asian (SAS)
AF:
0.212
AC:
1023
AN:
4818
European-Finnish (FIN)
AF:
0.186
AC:
1971
AN:
10584
Middle Eastern (MID)
AF:
0.173
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
0.175
AC:
11920
AN:
67992
Other (OTH)
AF:
0.199
AC:
420
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1106
2211
3317
4422
5528
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
304
608
912
1216
1520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.177
Hom.:
8050
Bravo
AF:
0.170
Asia WGS
AF:
0.164
AC:
570
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
4.6
DANN
Benign
0.64
PhyloP100
0.049
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3892225;
hg19: chr1-218553297;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.